Long-Term Effects of Secondary Prevention on Cognitive Function in Stroke Patients

被引:81
|
作者
Douiri, Abdel [1 ]
McKevitt, Christopher
Emmett, Eva S.
Rudd, Anthony G.
Wolfe, Charles D. A.
机构
[1] Kings Coll London, Div Hlth & Social Care Res, London SE1 3QD, England
关键词
drug therapy; mild cognitive impairment; prevention & control; stroke; vascular dementia; HEALTH-CARE PROFESSIONALS; TRANSIENT ISCHEMIC ATTACK; MINI-MENTAL-STATE; GUIDELINES; IMPAIRMENT; DEMENTIA; MANAGEMENT;
D O I
10.1161/CIRCULATIONAHA.113.002236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Limited long-term follow-up data exist on the impact of appropriate secondary prevention therapies on cognitive function in patients after first-ever stroke. The aim of this study is to determine the effect of secondary prevention of vascular events on cognitive function after stroke. Methods and Results Data were collected between 1995 and 2011 (n=4413) from the community-based South London Stroke Register covering an inner-city multiethnic source population of 271 817 inhabitants. Modified Poisson regression models were constructed to adjust for cognitive function status at 3 months, demographic and socioeconomic characteristics, case mix, stroke subtype, vascular risk factors, disability, and stroke recurrence. In patients with ischemic strokes without a history of atrial fibrillation (AF), there was a reduced risk of cognitive impairment associated with the use of different prevention treatments: (1) antihypertensives (relative risk, 0.7 [95% confidence interval, 0.57-0.82] for diuretics; relative risk, 0.8 [95% confidence interval, 0.64-0.98] for angiotensin-converting enzyme inhibitors; and relative risk, 0.7 [95% confidence interval, 0.55-0.81] for their combination), (2) a combination of aspirin and dipyridamole (relative risk, 0.8 [95% confidence interval, 0.68-1.01]), and (3) statin (relative risk, 0.9 [95% confidence interval, 0.76-1.06]) when clinically indicated. Protective effects against cognitive impairment were also observed in patients on the combination of antihypertensives, antithrombotic agents, and lipid-lowering drugs (relative risk, 0.55 [95% confidence interval, 0.40-0.77]). No significant associations were noted between poststroke cognitive impairment and antihypertensives among hemorrhagic stroke patients. Conclusions Appropriate vascular risk management was associated with a long-term reduced risk of cognitive impairment. Focus on optimal preventive drug therapy of vascular risk factors and management should be supported.
引用
收藏
页码:1341 / 1348
页数:8
相关论文
共 50 条
  • [1] Long-term effects of secondary prevention on cognitive function in stroke patients
    Douiri, A.
    McKevitt, C.
    Emmett, E. S.
    Rudd, A. G.
    Wolfe, C. D. A.
    CEREBROVASCULAR DISEASES, 2013, 35 : 187 - 187
  • [2] Prasugrel or clopidogrel for long-term secondary stroke prevention?
    Hankey, Graeme J.
    LANCET NEUROLOGY, 2019, 18 (03): : 222 - 223
  • [3] Long-term use of statins in secondary prevention of stroke
    Castilla-Guerra, L.
    Fernandez-Moreno, M. C.
    Castillo-Aguilar, C.
    Marin-Martin, J.
    Alvarez-Suero, J.
    Carmona-Nimo, E.
    Jimenez, M. D.
    Lopez-Chozas, J. M.
    JOURNAL OF NEUROLOGY, 2008, 255 : 40 - 40
  • [4] Long-term outcome and secondary prevention of cardioembolic stroke in severely disabled patients
    Jurjans, K.
    Miglane, E.
    Lurina, B.
    Kalejs, O.
    Priede, Z.
    Millers, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 251 - 251
  • [5] An evaluation of secondary stroke prevention in elderly long-term care patients.
    Hein, BE
    Patterson, TB
    PHARMACOTHERAPY, 2002, 22 (10): : 1339 - 1339
  • [6] Long-Term Effects of Chemo on the Cognitive Function of Cancer Patients
    Jim, Heather
    Rodin, Gary
    Ahles, Tim A.
    ONCOLOGY-NEW YORK, 2012, 26 (11): : 1012 - +
  • [7] Practice Variation in Long-term Secondary Stroke Prevention in The Netherlands
    van Schaik, Sander M.
    de Vries, Blanche S.
    Weinstein, Henry C.
    Visser, Marieke C.
    Van den Berg-Vos, Renske M.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (03): : 566 - 572
  • [8] A Prescription at Discharge Improves Long-term Adherence for Secondary Stroke Prevention
    Tsai, Jenny P.
    Rochon, Paula A.
    Raptis, Stavroula
    Bronskill, Susan E.
    Bell, Chaim M.
    Saposnik, Gustavo
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (09): : 2308 - 2315
  • [9] Secondary prevention and lifestyle indices after stroke in a long-term perspective
    Jonsson, A. C.
    Delavaran, H.
    Lovkvist, H.
    Baturova, M.
    Iwarsson, S.
    Stahl, A.
    Norrving, B.
    Lindgren, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (03): : 227 - 234
  • [10] Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke
    Nakase, Taizen
    Sasaki, Masahiro
    Suzuki, Akifumi
    CLINICAL AND TRANSLATIONAL MEDICINE, 2015, 4